(-)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice

Molecular Neurobiology

Volumn 49, Issue 3, 2014, Pages 1350-1363

  Liu, Mingyan ^a   Chen, Fujun ^a   Sha, Lei ^a   Wang, Shuang ^a   Tao, Lin ^a   Yao, Lutian ^a   He, Miao ^a   Yao, Zhimin ^a   Liu, Hang ^a   Zhu, Zheng ^a   Zhang, Zhenjie ^a   Zheng, Zhihong ^a   Sha, Xianzheng ^a   Wei, Minjie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

APP PS1 transgenic mouse; EGCG; Learning and memory deficits; NGF

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIGALLOCATECHIN GALLATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN RECEPTOR P75; PRESENILIN 1; PROTEIN TYROSINE KINASE A; RAF PROTEIN; CATECHIN; NERVE GROWTH FACTOR RECEPTOR; TNFRSF16 PROTEIN, MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; LEARNING DISORDER; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SPATIAL LEARNING; TRANSGENIC MOUSE; ANALOGS AND DERIVATIVES; ANIMAL; AVOIDANCE BEHAVIOR; DRUG EFFECTS; GENETICS; MALE; MEMORY DISORDERS; METABOLISM; PHYSIOLOGY;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AVOIDANCE LEARNING; CATECHIN; MALE; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; PRESENILIN-1; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84902551030     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8608-2     Document Type: Article

References (50)

1. Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101(5):1172-1184
2. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352-357
3. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274(5284):99-102 (Pubitemid 26332733)
4. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27(4):796-807 (Pubitemid 46174498)
5. Lovell MA, Markesbery WR (2007) Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 85(14):3036-3040 (Pubitemid 350057358)
6. Müller WE, Eckert A, Hartmann H, Velbinger K, Förstl H (1996) The calcium hypothesis of brain aging. Nervenarzt 67(1):15-24
7. Johnson EM Jr (1994) Possible role of neuronal apoptosis in Alzheimer's disease. Neurobiol Aging 15(Suppl 2):S187-S189
8. O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34:185-204
9. Counts SE, Mufson EJ (2005) The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J Neuropathol Exp Neurol 64:263-272 (Pubitemid 40489553)
10. Colafrancesco V, Villoslada P (2011) Targeting NGF-pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases. Arch Ital Biol 149(2):183-192
11. Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642 (Pubitemid 36930455)
12. Copray S, Kust B, Emmer B, Lin MY, Liem R, Amor S, de Vries H, Floris S, Boddeke E (2004) Deficient p75 low-affmity neurotrophin receptor expression exacerbates experimental allergic encephalomyelitis in C57/BL6 mice. J NeuroimmunoI 148(1-2):41-53 (Pubitemid 38229557)
13. Costantini C, Rossi F, Formaggio E, Bernardoni R, Cecconi D, Della-Bianca V (2005) Characterization of the signaling pathway down-stream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death. J Mol Neurosci 25(2):141-156 (Pubitemid 41389355)
14. Song W, Volosin M, Cragnolini AB, Hempstead BL, Friedman WJ (2010) ProNGF induces PTEN via p75NTR to suppress Trk-mediated survival signaling in brain neurons. J Neurosci 30(46):15608-15615
15. Fortress AM, Buhusi M, Helke KL, Granholm AC (2011) Cholingergic degeneration and alterations in the TrkA and p75NTR balance as a result of pro-NGF injection into aged rats. J Aging Res 2011:460543. doi:10.4061/2011/ 460543
16. Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6(8):603-614 (Pubitemid 41059335)
17. Lin YS, Tsai YJ, Tsay JS, Lin JK (2003) Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem 51(7):1864-1873
18. Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26(4):373S-388S
19. Wu CD, Wei GX (2002) Tea as a functional food for oral health. Nutrition 18(5):443-444 (Pubitemid 34414981)
20. Ahmed S, Pakozdi A, Koch AE (2006) Regulation of interleukin-1beta- induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 54(8):2393-2401 (Pubitemid 44204999)
21. Higuchi A, Yonemitsu K, Koreeda A, Tsunenari S (2003) Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation-a mechanism of protective effects of EGCg against paraquat toxicity. Toxicology 183(1-3):143-149 (Pubitemid 36005394)
22. Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP (2007) A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3- gallate as a potential anticancer agent. Cancer Res 67(9):4303-4310 (Pubitemid 46815078)
23. Jeong JH, Kim HJ, Lee TJ, Kim MK, Park ES, Choi BS (2004) Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine. Toxicology 195(1):53-60 (Pubitemid 38036982)
24. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou HY, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25(38):8807-8814 (Pubitemid 41362059)
25. Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT (2009) Green tea (-)-epigallocatechin-3-Gallate inhibits β-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-κB Pathways in Mice. J Nutr 139(10):1987-1993
26. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 12(1214):177-187
27. He M, Zhao L, Wei MJ, Yao WF, Zhao HS, Chen FJ (2009) Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by D-galactose. Biol Pharm Bull 32(1):55-60
28. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17(6):157-165 (Pubitemid 32409891)
29. van Groen T, Kiliaan AJ, Kadish I (2006) Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. Neurobiol Dis 23(3):653-662 (Pubitemid 44234102)
30. Bornemann KD, Staufenbiel M (2000) Transgenic mouse models of Alzheimer's disease. Ann N Y Acad Sci 908:260-266 (Pubitemid 30462010)
31. Galeotti N, Ghelardini C, Bartolini A (1998) Role of 5-HT4 receptors in the mouse passive avoidance test. J Pharmacol Exp Ther 286(3):1115-1121 (Pubitemid 29135518)
32. Tsuji M, Takeda H, Matsumiya T (2003) Modulation of passive avoidance in mice by the 5-HT1A receptor agonist flesinoxan: comparison with the benzodiazepine receptor agonist diazepam. Neuropharmacology 28(4):664-674
33. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11(1):47-60
34. Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1(2):848-858
35. Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221(2):555-563
36. Houehand G, Romani A, Marchetti C, Amato G, Capsoni S, Cattaneo A, Marie H (2010) Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities. J Neurosci 30(39):13089-13094
37. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1997) Accelerated amyloid deposition in t he brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19(4):939-945 (Pubitemid 27471397)
38. Jia N, Han K, Kong JJ, Zhang XM, Sha S, Ren GR, Cao YP (2013) (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Mol Cell Biochem 380:211-218
39. Lee SJ, Lee KW (2007) Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Biol Pharm Bull 30(8):1369-1373
40. Koh SH, Kim SH, Kwon H, Park Y, Kim KS, Song CW, Kim J, Kim MH, Yu HJ, Henkel JS, Jung HK (2003) Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Mol Brain Res 118(1-2):72-81 (Pubitemid 37238989)
41. Freedman SB, Morris RG (2000) A learing deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408(6815):975-979 (Pubitemid 32101643)
42. Capsoni S, Brandi R, Arisi I, D'Onofrio M, Cattaneo A (2011) A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model. CNS Neurol Disord Drug Targets 10(5):635-647
43. Williams B, Granholm AC, Sambamurti K (2007) Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation. Neurosci Lett 413(2):110-114 (Pubitemid 46177399)
44. Autio H, Mätlik K, Rantamäki T, Lindemann L, Hoener MC, Chao M, Arumäe U, Castrén E (2011) Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology 61(8):1291-1296
45. De Felice FG, Wasilewska-Sampaio AP, Barbosa AC, Gomes FC, Klein WL, Ferreira ST (2007) Cyclic AMP enhancers and Abeta oligomerization blockers as potential therapeutic agents in Alzheimer's disease. Curr Alzheimer Res 4(3):263-271 (Pubitemid 47025424)
46. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114:1624-1634 (Pubitemid 40385553)
47. Chu J, Praticò D (2011) 5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo. Ann Neurol 69(1):34-46
48. Tong LQ, Thornton PL, Balazs R, Cotman CW (2001) β-amyloid-(1-42) impairs acivity-dependent cAMP-response-elment-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J Biol Chem 276(20):17301-17306
49. Matrone C, Barbagallo AP, Rosa LR, Florenzano F, Ciotti MT, Mercanti D, Chao MV, Calissano P, D'Adamio L (2011) APP is phosphorylated by TrkA and regulates NGF/TrkA signaling. J Neurosci 31(33):11756-11761
50. Hashimoto Y, Kaneko Y, Tsukamoto E, Frankowski H, Kouyama K, Kita Y, Niikura T, Aiso S, Bredesen DE, Matsuoka M, Nishimoto I (2004) Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD. J Neurochem 90(3):549-558 (Pubitemid 38989385)